[A case of meningoencephalitis that developed during nivolumab use].

Suzuki, Yu; Sakurai, Kenzo; Uchino, Kenji; Inoue, Takeo; Takahashi, Toshiyuki; Hasegawa, Yasuhiro; Yamano, Yoshihisa

Suzuki, Yu; Sakurai, Kenzo; Uchino, Kenji; Inoue, Takeo; Takahashi, Toshiyuki; Hasegawa, Yasuhiro; Yamano, Yoshihisa.

Afiliação

Suzuki Y; Division of Neurology, Department of Internal Medicine, St Marianna University School of Medicine.
Sakurai K; Department of Neurology, Shinyurigaoka General Hospital.
Uchino K; Division of Neurology, Department of Internal Medicine, St Marianna University School of Medicine.
Inoue T; Division of Neurology, Department of Internal Medicine, St Marianna University School of Medicine.
Takahashi T; Division of Neurology, Department of Internal Medicine, Kawasaki Municipal Tama Hospital.
Hasegawa Y; Division of Respiratory Medicine, Department of Internal Medicine, St Marianna University School of Medicine.
Yamano Y; National Epilepsy Center, NHO Shizuoka Institute of Epilepsy and Neurological Disorders.

Nihon Ronen Igakkai Zasshi ; 58(4): 624-629, 2021.

Article em Ja | MEDLINE | ID: mdl-34880182

Assuntos

Adenocarcinoma de Pulmão; Encefalite; Neoplasias Pulmonares; Meningoencefalite; Adenocarcinoma de Pulmão/tratamento farmacológico; Idoso; Feminino; Humanos; Neoplasias Pulmonares/tratamento farmacológico; Imageamento por Ressonância Magnética; Meningoencefalite/induzido quimicamente; Nivolumabe/efeitos adversos

Palavras-chave

Anti-glutamate receptor antibody; Immune checkpoint inhibitors; Nivolumab-related encephalitis; Steroid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encefalite / Adenocarcinoma de Pulmão / Neoplasias Pulmonares / Meningoencefalite Limite: Aged / Female / Humans Idioma: Ja Revista: Nihon Ronen Igakkai Zasshi Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google